ZBIO

Zenas BioPharma
ZBIO

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$1.67B
EV
$1.40B
Shares Outstanding
59.79M
Beta
-
Industry
Biotechnology

Wall Street View

Analyst Rating
BUY
Analyst Target Price
Number of Analysts
7
P/E 2025E
-
P/Revenue 2025E
39.36x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Zenas BioPharma, Inc.

gainify
ZBIO

Zenas BioPharma, Inc.

ZBIO

Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody for various indications, incl...

Sector

Healthcare

Industry

Biotechnology

CEO

Moulder, Leon

Employees

130

IPO Date

2024-09-13

Headquarters

North Building, Suite 1200, 1000 Winter Street, Waltham, Massachusetts, 02451, United States

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.